Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

This study has been terminated.

Study NCT00038870 Information provided by M.D. Anderson Cancer Center

First Received: June 5, 2002 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given